Clinical Trial Update: Pharmacogenetics-guided Isoniazid Dosing in TB-HIV [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacogenetics-guided isoniazid dosing in tuberculosis and HIV co-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Makerere University | Conditions: Tuberculosis | Phase 2 | Status: UNKNOWN